Ying Huang
CIK: 0001967360
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Huang Ying
Huang Ying (SEC CIK 0001967360) files insider reports with the SEC as Director of ADARx Pharmaceuticals, Inc. (ADRX), Director of TCGX Acquisition Corp. (TCGX) and Chief Executive Officer of Legend Biotech Corp (LEGN).
Signal8 holds 6 ownership filings by Huang Ying (3 Form 3, 3 Form 4), filed between Mar 18, 2026 and Sep 24, 2026. Those filings report 3 transactions, from Mar 25, 2026 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Huang Ying's filings is in SAN DIEGO, CA.
Recent filings by Huang Ying
Other insiders filing for ADARx Pharmaceuticals, Inc. (ADRX)
- SR ONE CAPITAL MANAGEMENT, LLC, 10% Owner
- George Simeon, Director
- LAV Biosciences Fund V, L.P., 10% Owner
- Zhu Rui (NMN), Chief Technology Officer
- MacLeod Alan Robert, Chief Scientific Officer
- Fisk Ryan, CFO and CBO